The Food and Drug Administration (FDA) has issued a mandatory recall order for all dietary supplements and food products containing kratom manufactured, packed or held by Triangle Pharmaceuticals LLC, after several of the products were found to contain Salmonella. The agency took this action after the company failed to voluntarily recall their products.
Consumers are advised to discard any kratom products from Triangle Pharmaceuticals including Raw Form Organics Maeng da Kratom Emerald Green, Raw Form Organics Maeng Da Kratom Ivory White, and Raw Form Organics Maeng Da Kratom Ruby Red. There may be additional brands of kratom-containing capsules, powders or food manufactured, produced, packed and/or held by Triangle Pharmaceuticals, and they, too, should be avoided because they pose a risk to consumers’ health.
The announcement comes after an investigation by the FDA, the Centers for Disease Control & Prevention (CDC), and state and local agencies into a multi-state outbreak of Salmonella in people who consumed kratom products. At least 87 people have been sickened in 35 states; 27 of those who fell ill required hospitalization.
The FDA announced that laboratory testing had revealed several kratom products were contaminated with Salmonella and several companies, including PDX Aromatics issued recalls of their kratom-containing products. Earlier this week, Nutrizone expanded its recall to include more brands.
Kratom is an herb that is often marketed as a dietary or herbal supplement to treat pain, diarrhea or opioid addiction. It can also give users a feeling of euphoria.
Salmonella is an organism that causes symptoms such as diarrhea (which can be bloody), fever and abdominal cramps. In some people, the diarrhea can be so severe that they need to be hospitalized. In rare cases, Salmonella infection may spread from the intestines to the bloodstream and then to other body sites and cause death unless the person is promptly treated with antibiotics. Children, the elderly, and those with weakened immune systems are most at risk of developing severe infections.
FDA News Release
FDA Recall Notices